Anti-vertigo drug prescribing for patients with vestibular symptoms in primary care: a retrospective observational cohort study
Hà TN Ngo, Otto R Maarsingh, Pauline Slottje, Marco H Blanker, Feikje Groenhof, Jettie Bont, Vincent A van Vugt · 2025
Read Anti-vertigo drug prescribing for patients with vestibular symptoms in primary care: a retrospective observational cohort study by Hà TN Ngo, Otto R Maarsingh, Pauline Slottje, Marco H Blanker, Feikje Groenhof, Jettie Bont, Vincent A van Vugt (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12820506.txt.
Description
Ha Ngo and co-authors examine how often family doctors prescribe anti-vertigo drugs, and for how long, in this 2025 study. Evidence that these drugs help dizziness is thin. One of them, betahistine, is still among the most prescribed off-label drugs. Doctors in primary care likely write much of that volume. The team mined records from hundreds of Dutch practices. More than a million patients' data covered the years 2018 to 2021.
They counted new and long-term prescriptions for patients with balance symptoms. Traits linked to long-term use were also sought. Long courses are the worry when benefit is unproven. The study is records-based, with identities removed. Its findings can feed prescribing guidance and review campaigns. Dizzy patients are common in primary care, so even small rates mean many people.
Catalog record
| CREATOR | Hà TN Ngo, Otto R Maarsingh, Pauline Slottje, Marco H Blanker, Feikje Groenhof, Jettie Bont, Vincent A van Vugt |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |